Archives of Clinical Infectious Diseases

Published by: Kowsar

Specific Identification and Antifungal Susceptibility Pattern of Clinically Important Dermatophyte Species Isolated from Patients with Dermatophytosis in Tehran, Iran

Mehraban Falahati 1 , Roohollah Fateh 2 , 3 , * , Abouzar Nasiri 4 , ** , Farideh Zaini 5 , Azam Fattahi 6 and Shirin Farahyar 1
Authors Information
1 Department of Parasitology and Mycology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, IR Iran
2 Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, IR Iran
3 Department of Microbiology and Immunology, Faculty of Medicine, Qom University of Medical Sciences, Qom, IR Iran
4 Department of Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
5 Department of Parasitology and Mycology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
6 Center for Research and Training in Skin Disease and Leprosy, Tehran University of Medical Sciences, Tehran, IR Iran
Corresponding Authors:
Article information
  • Archives of Clinical Infectious Diseases: June 2018, 13 (3); e63104
  • Published Online: June 25, 2018
  • Article Type: Research Article
  • Received: April 10, 2017
  • Revised: October 21, 2017
  • Accepted: December 10, 2017
  • DOI: 10.5812/archcid.63104

To Cite: Falahati M, Fateh R, Nasiri A, Zaini F, Fattahi A, et al. Specific Identification and Antifungal Susceptibility Pattern of Clinically Important Dermatophyte Species Isolated from Patients with Dermatophytosis in Tehran, Iran, Arch Clin Infect Dis. 2018 ; 13(3):e63104. doi: 10.5812/archcid.63104.

Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Bhatia VK, Sharma PC. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method. Indian J Med Microbiol. 2015;33(4):533-7. doi: 10.4103/0255-0857.167341. [PubMed: 26470960].
  • 2. Bhatia VK, Sharma PC. Epidemiological studies on Dermatophytosis in human patients in Himachal Pradesh, India. Springerplus. 2014;3:134. doi: 10.1186/2193-1801-3-134. [PubMed: 25674437]. [PubMed Central: PMC4320242].
  • 3. Rezaei-Matehkolaei A, Makimura K, Shidfar M, Zaini F, Eshraghian M, Jalalizand N, et al. Use of Single-enzyme PCR-restriction Digestion Barcode Targeting the Internal Transcribed Spacers (ITS rDNA) to Identify Dermatophyte Species. Iran J Public Health. 2012;41(3):82-94. [PubMed: 23113152]. [PubMed Central: PMC3481703].
  • 4. Fernandez-Torres B, Carrillo AJ, Martin E, Del Palacio A, Moore MK, Valverde A, et al. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother. 2001;45(9):2524-8. [PubMed: 11502524]. [PubMed Central: PMC90687].
  • 5. Chadeganipour M, Nilipour S, Havaei A. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan. Mycoses. 2004;47(11-12):503-7. doi: 10.1111/j.1439-0507.2004.01050.x. [PubMed: 15601457].
  • 6. Roberts BJ, FriedIander SF. Tinea Capitis: A Treatment Update. PediatrAnn. 2005;34(3):191-200. doi: 10.3928/0090-4481-20050301-08.
  • 7. Gupta AK, Williams JV, Zaman M, Singh J. In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patients. Med Mycol. 2009;47(8):796-801. doi: 10.3109/13693780802712523. [PubMed: 19212895].
  • 8. Fuller LC, Smith CH, Cerio R, Marsden RA, Midgley G, Beard AL, et al. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis. Br J Dermatol. 2001;144(2):321-7. [PubMed: 11251566].
  • 9. Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol. 2005;53(6):931-51. quiz 952-4. doi: 10.1016/j.jaad.2004.10.883. [PubMed: 16310053].
  • 10. Pakshir K, Bahaedinie L, Rezaei Z, Sodaifi M, Zomorodian K. In vitro activity of six antifungal drugs against clinically important dermatophytes. Jundishapur J Microb. 2009;2(4):158-63.
  • 11. da Silva Barros ME, de Assis Santos D, Hamdan JS. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). J Med Microbiol. 2007;56(Pt 4):514-8. doi: 10.1099/jmm.0.46542-0. [PubMed: 17374893].
  • 12. Adimi P, Hashemi SJ, Mahmoudi M, Mirhendi H, Shidfar MR, Emmami M, et al. In-vitro activity of 10 antifungal agents against 320 dermatophyte strains using microdilution method in Tehran. Iran J Pharm Res. 2013;12(3):537.
  • 13. Noorbakhsh F, Rezaie S, Shahverdi AR. Antifungal effects of silver nanoparticle alone and with combination of antifungal drug on dermatophyte pathogen Trichophyton rubrum. International conference on bioscience, biochemistry and bioinformatics. 2011. p. 364-7.
  • 14. Mikaeili A, Modaresi M, Karimi I, Ghavimi H, Fathi M, Jalilian N. Antifungal activities of Astragalus verus Olivier. against Trichophyton verrucosum on in vitro and in vivo guinea pig model of dermatophytosis. Mycoses. 2012;55(4):318-25. doi: 10.1111/j.1439-0507.2011.02090.x. [PubMed: 21838718].
  • 15. Massiha A, Muradov PZ. Comparison of Antifungal Activity of Extracts of Ten Plant Species and Griseofulvin Against Human Pathogenic Dermatophytes. Zahedan J Res Med Sci. 2015;17(10). doi: 10.17795/zjrms-2096.
  • 16. Ansari S, Hedayati MT, Zomorodian K, Pakshir K, Badali H, Rafiei A, et al. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran. Mycopathologia. 2016;181(1-2):89-95. doi: 10.1007/s11046-015-9941-y. [PubMed: 26369643].
  • 17. Rezaei-Matehkolaei A, Makimura K, de Hoog S, Shidfar MR, Zaini F, Eshraghian M, et al. Molecular epidemiology of dermatophytosis in Tehran, Iran, a clinical and microbial survey. Med Mycol. 2013;51(2):203-7. doi: 10.3109/13693786.2012.686124. [PubMed: 22587730].
  • 18. Wayne P. Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. CLSI document M27-A3 and Supplement S. 2008;3:6-12.
  • 19. Wayne P. Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. CLSI document M38-A2. CLSI. 2008;2:6-12.
  • 20. Abastabar M, Rezaei-Matehkolaei A, Shidfar MR, Kordbacheh P, Mohammadi R, Shokoohi T, et al. A Molecular Epidemiological Survey of Clinically Important Dermatophytes in Iran Based on Specific RFLP Profiles of Beta-tubulin Gene. Iran J Public Health. 2013;42(9):1049-57. [PubMed: 26060667]. [PubMed Central: PMC4453885].
  • 21. Arikan S. Current status of antifungal susceptibility testing methods. Med Mycol. 2007;45(7):569-87. doi: 10.1080/13693780701436794. [PubMed: 17885947].
  • 22. Silva LB, de Oliveira DB, da Silva BV, de Souza RA, da Silva PR, Ferreira-Paim K, et al. Identification and antifungal susceptibility of fungi isolated from dermatomycoses. J Eur Acad Dermatol Venereol. 2014;28(5):633-40. doi: 10.1111/jdv.12151. [PubMed: 23556501].
  • 23. Carrillo-Munoz AJ, Giusiano G, Cardenes D, Hernandez-Molina JM, Eraso E, Quindos G, et al. Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis. Int J Antimicrob Agents. 2008;31(6):540-3. doi: 10.1016/j.ijantimicag.2008.01.023. [PubMed: 18367383].
  • 24. Bueno JG, Martinez C, Zapata B, Sanclemente G, Gallego M, Mesa AC. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis. Clin Exp Dermatol. 2010;35(6):658-63. doi: 10.1111/j.1365-2230.2009.03698.x. [PubMed: 19874354].
  • 25. Ataides FS, Chaul MH, El Essal FE, Costa CR, Souza LK, Fernandes OF, et al. Antifungal susceptibility patterns of yeasts and filamentous fungi isolated from nail infection. J Eur Acad Dermatol Venereol. 2012;26(12):1479-85. doi: 10.1111/j.1468-3083.2011.04315.x. [PubMed: 22049990].
  • 26. Perea S, Fothergill AW, Sutton DA, Rinaldi MG. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method. J Clin Microbiol. 2001;39(1):385-8. doi: 10.1128/JCM.39.1.385-388.2001. [PubMed: 11136808]. [PubMed Central: PMC87739].
  • 27. Jo Siu WJ, Tatsumi Y, Senda H, Pillai R, Nakamura T, Sone D, et al. Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis. Antimicrob Agents Chemother. 2013;57(4):1610-6. doi: 10.1128/AAC.02056-12. [PubMed: 23318803]. [PubMed Central: PMC3623347].
  • 28. Esteban A, Abarca ML, Cabanes FJ. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes. Med Mycol. 2005;43(1):61-6. doi: 10.1080/13693780410001711972.
  • 29. Galuppi R, Gambarara A, Bonoli C, Ostanello F, Tampieri MP. Antimycotic effectiveness against dermatophytes: comparison of two in vitro tests. Vet Res Commun. 2010;34 Suppl 1:S57-61. doi: 10.1007/s11259-010-9386-1. [PubMed: 20490661].
  • 30. Scholz R, Meinhof W. Susceptibility of Trichophyton rubrum to griseofulvin. Mycoses. 2009;34(9-10):411-4. doi: 10.1111/j.1439-0507.1991.tb00804.x.
  • 31. Korting HC, Ollert M, Abeck D. Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. German Collaborative Dermatophyte Drug Susceptibility Study Group. Antimicrob Agents Chemother. 1995;39(5):1206-8. [PubMed: 7625820]. [PubMed Central: PMC162715].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments